Atrioventricular Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillation (AF), Heart Failure and Preserved Ejection Fraction: Heart Rate Regularization Versus Medical Rate Control
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 266 participants.
Also called NCT06833138
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 266 participants
- Sponsor
- Registry
-
NCT06833138
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Recruiting
Technical summary
Registry record NCT06833138. Randomized; single masking; primary purpose treatment. Start 2025-09-10 (actual); primary completion 2029-05-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Atrioventricular Node Ablation and Conduction System Pacing in Patients With Well Controlled Permanent Atrial Fibrillation (AF), Heart Failure and Preserved Ejection Fraction: Heart Rate Regularization Versus Medical Rate Control
- Acronym
- HF-RELIEF
- Condition
- Atrial Fibrillation, Persistent
- Intervention (Procedure)
- pacemaker implantation
- Intervention (Procedure)
- atrioventricular node ablation
- Intervention (Device)
- Pacemaker programming
- Lead sponsor
- French Cardiology Society
- Collaborator
- Medtronic France SAS
Record details
- Record id
cardio:ct-nct06833138- Content hash
ed059daa3651e1c44faa0cea314d5d09ab214855967e5d16229d456b58f451a4